William Pollock
Medical · Corona, CANPI 1881867919
Payments from drug & device makers
Across 204 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$504
- AstraZeneca$428
- Novo Nordisk$416
- Teva Pharmaceuticals USA, Inc.$353
- Lilly USA, LLC$247
- Amgen$230
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,041100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $504 |
| AstraZeneca | 20 | $428 |
| Novo Nordisk | 23 | $416 |
| Teva Pharmaceuticals USA, Inc. | 18 | $353 |
| Lilly USA, LLC | 15 | $247 |
| Amgen | 12 | $230 |
| Boehringer Ingelheim | 10 | $198 |
| GSK | 7 | $169 |
| Pfizer | 9 | $154 |
| Merck | 9 | $129 |
| Astellas Pharma US Inc | 5 | $119 |
| Bayer | 5 | $104 |
| Novartis | 5 | $96 |
| Biohaven Pharmaceuticals, Inc. | 5 | $91 |
| Sumitomo Pharma America, Inc. | 5 | $90 |
| Eisai Inc. | 4 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $64 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $60 |
| Si-bone, Inc. | 2 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $44 |
| Edwards Lifesciences | 2 | $43 |
| Sunovion Pharmaceuticals Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Bausch Health US, LLC | 2 | $37 |
| Ardelyx, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Tonix Medicines, Inc. | 1 | $24 |
| Evoke Pharma, Inc. | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Antares Pharma, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| UCB, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Exact Sciences | 1 | $14 |
How this compares
$4,041 in reported general payments places this provider in the 85th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 68 | $67,871 |
| JardianceEmpagliflozin | 64 | $51,713 |
| FarxigaDapagliflozin Propanediol | 18 | $22,629 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 23 | $22,545 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $21,951 |
| XareltoRivaroxaban | 13 | $16,960 |
| MultaqDronedarone Hcl | 12 | $9,854 |
| Atrovent HfaIpratropium Bromide | 19 | $9,106 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,417 |
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $7,822 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 58 | $6,204 |
| CymbaltaDuloxetine Hcl | 12 | $3,378 |
| DayvigoLemborexant | 11 | $3,355 |
| Gabapentin | 170 | $3,114 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 111 | $2,887 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $154 | $67,87168 claims |
| Boehringer IngelheimJardiance | $198 | $51,71364 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $428 | $31,04631 claims |
| MerckJanumet Xr, Janumet | $129 | $30,36737 claims |
| GSKTrelegy Ellipta | $169 | $21,95135 claims |
| Sanofi-aventis U.S. LLCMultaq | $39 | $9,85412 claims |
| Lilly USA, LLCCymbalta | $247 | $3,37812 claims |
| Eisai Inc.Dayvigo | $81 | $3,35511 claims |
| Teva Pharmaceuticals USA, Inc.Acyclovir | $353 | $72014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 medical providers in California.
Other medical in Corona
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.